We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy
Evidence-based coverage of pharmaceutical development, regulatory affairs, and biotech innovation
Amidst a burgeoning body of research, we're continually unravelling new facets of the versatile drug ketamine. A case in point is recent studies indicating another feather in ketamine's cap: treating
Read ArticleThe National Health Service (NHS) has recently introduced a new pharmacy plan aimed at reducing the length of stay for patients in hospitals. The plan seeks to streamline the discharge process for pat
In the highly competitive world of pharmaceuticals, companies are constantly looking for the next big breakthrough drug. The quest for new treatments can be a risky and expensive endeavour, with no gu
Cervical cancer is one of the main reasons women die, but it can be stopped if it is found and treated early. In recent years, much progress has been made in the fight against cervical cancer, with th
Following the worldwide COVID-19 outbreak, the pharmaceutical industry faces both potential and increased complications. In the near future, there are a few important things for pharma to keep an eye
It has been called "historic" that the first drug to slow the brain damage caused by Alzheimer's has been made. The scientific discovery puts a stop to decades of futility and demonstrates that new me
It is still attempting to resolve the fundamental issue. In general, Mark Cuban's new online pharmacy is delivering on its promises of offering low savings on hundreds of prescription medications. The
Subscribe to our weekly pharmaceutical intelligence digest